4.8 Article

Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2

Journal

NATURE COMMUNICATIONS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms8274

Keywords

-

Funding

  1. German Research Foundation [ZA 186/4-1, CRSII3_141811]
  2. Swiss National Science Foundation [PPP0033-114898, CRSII3-141811]
  3. People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 [317250]
  4. Swiss National Science Foundation (SNF) [CRSII3_141811] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The lymphatic system maintains tissue fluid balance, and dysfunction of lymphatic vessels and valves causes human lymphedema syndromes. Yet, our knowledge of the molecular mechanisms underlying lymphatic vessel development is still limited. Here, we show that cyclin-dependent kinase 5 (Cdk5) is an essential regulator of lymphatic vessel development. Endothelial-specific Cdk5 knockdown causes congenital lymphatic dysfunction and lymphedema due to defective lymphatic vessel patterning and valve formation. We identify the transcription factor Foxc2 as a key substrate of Cdk5 in the lymphatic vasculature, mechanistically linking Cdk5 to lymphatic development and valve morphogenesis. Collectively, our findings show that Cdk5-Foxc2 interaction represents a critical regulator of lymphatic vessel development and the transcriptional network underlying lymphatic vascular remodeling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available